The interplay between TGF-β and IL-6 which are both expressed at high levels in MM bone marrow may affect generation of Th17 cells both directly and via other proinflammatory cytokines and thereby modulate antitumor immune responses [89, 90]. This evidence concerns the gene IL6 and Miyoshi myopathy.